Arterra Bioscience S.p.A. (BIT:ARBS)

Market Cap	20.31M +21.0%
Revenue (ttm)	4.70M +34.8%
Net Income	2.01M +65.7%
EPS	0.30
Shares Out	6.66M
PE Ratio	10.12
Forward PE	n/a
Dividend	0.13 (4.21%)
Ex-Dividend Date	May 4, 2026

Volume	2,250
Open	3.050
Previous Close	3.120
Day's Range	3.050 - 3.110
52-Week Range	2.500 - 3.580
Beta	0.64
Analysts	n/a
Price Target	n/a
Earnings Date	Sep 28, 2026

About Arterra Bioscience

Arterra Bioscience S.p.A., a research-based biotech company, engages in the research and development of various ingredients and natural solutions. The company provides extraction processes, and raw materials for use in the cosmetics, agriculture, and nutraceuticals sectors. Arterra Bioscience S.p.A. was founded in 2003 and is based in Naples, Italy.

• Industry: Biotechnology
• Sector: Healthcare
• Founded: 2003
• Employees: 36
• Stock Exchange: Borsa Italiana
• Ticker Symbol: ARBS

Financial Performance

In 2025, Arterra Bioscience's revenue was 4.70 million, an increase of 12.74% compared to the previous year's 4.17 million. Earnings were 2.01 million, an increase of 50.09%.

Data Sources: S&P Global Market Intelligence and Financial Modeling Prep

Fundamental and historical data is provided by S&P Global Market Intelligence. Delayed stock pricing data is provided by Financial Modeling Prep.

Last checked:

Sep 4, 2026

Data Sources Report a data error